Literature DB >> 32486856

New Paradigms in Diabetes Management From the Epicenter.

Carol J Levy1,2, Camilla M Levister1, Nirali A Shah1.   

Abstract

Entities:  

Keywords:  COVID-19; diabetes; inpatient management; telehealth

Mesh:

Substances:

Year:  2020        PMID: 32486856      PMCID: PMC7673171          DOI: 10.1177/1932296820930040

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


× No keyword cloud information.
  5 in total

1.  Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study.

Authors:  Lakshmi G Singh; David L Levitt; Medha Satyarengga; Lillian Pinault; Min Zhan; John D Sorkin; Jeffrey C Fink; Guillermo E Umpierrez; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2019-11-28

Review 2.  Continuous glucose monitoring in the ICU: clinical considerations and consensus.

Authors:  James S Krinsley; J Geoffrey Chase; Jan Gunst; Johan Martensson; Marcus J Schultz; Fabio S Taccone; Jan Wernerman; Julien Bohe; Christophe De Block; Thomas Desaive; Pierre Kalfon; Jean-Charles Preiser
Journal:  Crit Care       Date:  2017-07-31       Impact factor: 9.097

3.  The effective use of telemedicine to save lives and maintain structure in a healthcare system: Current response to COVID-19.

Authors:  Adel Elkbuli; Haley Ehrlich; Mark McKenney
Journal:  Am J Emerg Med       Date:  2020-04-07       Impact factor: 2.469

4.  Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.

Authors:  Robin Ohannessian; Tu Anh Duong; Anna Odone
Journal:  JMIR Public Health Surveill       Date:  2020-04-02

Review 5.  The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.

Authors:  Wen Zhang; Yan Zhao; Fengchun Zhang; Qian Wang; Taisheng Li; Zhengyin Liu; Jinglan Wang; Yan Qin; Xuan Zhang; Xiaowei Yan; Xiaofeng Zeng; Shuyang Zhang
Journal:  Clin Immunol       Date:  2020-03-25       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.